Coagulopathy in Malnourished Mice Is Sexually Dimorphic and Regulated by Nutrient‐Sensing Nuclear Receptors

Geoffrey A. Preidis, Krishnakant G. Soni, Ji Ho Suh, Tripti Halder, Kang Ho Kim, Jong Min Choi, Feng Li, Sridevi Devaraj, Margaret E. Conner, Cristian Coarfa, Sung Yun Jung, David D. Moore – 22 October 2020 – Liver dysfunction, including coagulopathy, is a prominent feature of protein‐energy malnutrition. To identify mechanisms underlying malnutrition‐associated coagulopathy, we administered a low‐protein low‐fat diet to lactating dams and examined hepatic transcription and plasma coagulation parameters in young adult weanlings.

Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery

Patrick Starlinger, David Pereyra, Hubert Hackl, Gregor Ortmayr, Eva Braunwarth, Jonas Santol, Sina Najarnia, Michael R. Driedger, Lindsey Gregory, Roberto Alva‐Ruiz, Amy Glasgow, Alice Assinger, David M. Nagorney, Elizabeth B. Habermann, Stefan Staetttner, Sean P. Cleary, Rory L. Smoot, Thomas Gruenberger – 20 October 2020

Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System

Angela Lamarca, Alvaro Santos‐Laso, Kirsten Utpatel, Adelaida La Casta, Simone Stock, Alejandro Forner, Jorge Adeva, Trine Folseraas, Luca Fabris, Rocio I.R. Macias, Marcin Krawczyk, Marek Krawczyk, Vincenzo Cardinale, Chiara Braconi, Domenico Alvaro, Matthias Evert, Jesus M. Banales, Juan W. Valle, for the Group: on behalf of the European Network for the Study of Cholangiocarcinoma (ENS‐CCA) – 18 October 2020

Liver Injury in Patients Hospitalized with Coronavirus Disease 2019 Correlates with Hyperinflammatory Response and Elevated Interleukin‐6

Ben L. Da, Tatyana Kushner, Maan El Halabi, Pavan Paka, Mian Khalid, Angad Uberoi, Brian T. Lee, Ponni V. Perumalswami, Stephanie M. Rutledge, Thomas D. Schiano, Scott L. Friedman, Behnam Saberi – 16 October 2020 – Liver injury is commonly seen in coronavirus disease 2019 (COVID‐19); however, the mechanism behind liver injury, particularly in patients with severe and critical COVID‐19, remains unclear, and the clinical course is poorly described.

LiverLearning®: Fundamentals of Liver Disease - Hepatitis B 2.0

DESCRIPTION There is currently an anticipated shortage of trained providers capable of diagnosing and treating different liver diseases. As a result of this increased demand and limited specialists in the field, more and more front-line providers are faced with these patients and do not have the experience or resources that will allow them to manage them appropriately.

Subscribe to